New nutrient cocktail shows promise in reversing autism symptoms in mice

A new study suggests that a low-dose mixture of zinc, serine, and branched-chain amino acids (BCAAs) could help reduce behavioural deficits in mice with autism spectrum disorder (ASD). Researchers tested the cocktail on three different mouse models, finding improvements in social behaviour and brain function. The findings propose a potential dietary approach for addressing ASD-related challenges in neural development.

The team behind the research believed that combining zinc, serine, and BCAAs would work better than any single supplement alone. They also hypothesised that lower doses of each could be used effectively. Their experiments showed that the mixture improved communication between neurons in the brain, particularly in the amygdala, where abnormal hyperactivity was reduced.

The cocktail was tested on three ASD mouse models: Shank2 mice, Nf1 mice, and Cttnbp2 mice. In all cases, the animals displayed better social behaviours after receiving the treatment. The supplements also altered protein expression in the synapses, making them more similar to those in healthy mice. The study argued that a 'one gene-one therapy' approach is impractical for ASD due to its complexity. Instead, the researchers suggested that a low-dose nutrient mixture could provide a safer, more practical long-term solution for broader application.

The findings indicate that dietary supplementation with zinc, serine, and BCAAs may help correct synaptic and behavioural deficits in ASD mouse models. By reducing neuronal hyperactivity and improving protein expression, the cocktail offers a potential therapeutic strategy. Further research would be needed to determine if similar effects could apply to humans.